A clinical-stage company dedicated to advancing therapies that restore lung health.
Our product, ARINA·1, has been developed to change the lives of individuals with a lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), and chronic bronchitis (CB).
In our target diseases, thick mucus often accumulates in the lungs and cannot be effectively cleared out of the airways, which leads to mucus plugging and difficulty breathing.
